Altre lingue Northwest Biotherapeutics, Inc.

Azioni

NWBO

US66737P6007

Tempo differito OTC Markets Altri mercati azionari 16:56:17 28/06/2024			Variaz. 5gg	Var. 1 gen.
0,4369 ^USD	+1,25%		-4,81%	-37,67%

10/05	Northwest Biotherapeutics, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
21/03	Northwest Biotherapeutics, Inc. nomina Pat Sarma nel suo Consiglio di Amministrazione	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property	17/06
Northwest Biotherapeutics: Q1 Earnings Snapshot	10/05
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	21/03
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	14/03
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification	06/02
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma	22/12
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma	21/12
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma	21/12
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application	22/11
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC	10/11
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)	19/10/23
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application	16/10/23
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application	13/10/23
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE	28/09/23
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)	25/09/23
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)	14/09/23
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)	13/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Northwest Biotherapeutics, Inc.

Azioni

NWBO

US66737P6007

Altre lingue

Filtri